Picture of virus under microscope

Research under the microscope...

The Strathprints institutional repository is a digital archive of University of Strathclyde research outputs.

Strathprints serves world leading Open Access research by the University of Strathclyde, including research by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), where research centres such as the Industrial Biotechnology Innovation Centre (IBioIC), the Cancer Research UK Formulation Unit, SeaBioTech and the Centre for Biophotonics are based.

Explore SIPBS research

Mechanistic studies on the enzymatic processing of fluorinated methionine analogs by Trichomonas vaginalis methionine γ-lyase

Moya, Ignace A and Westrop, Gareth D and Coombs, Graham H and Honek, John F (2011) Mechanistic studies on the enzymatic processing of fluorinated methionine analogs by Trichomonas vaginalis methionine γ-lyase. Biochemical Journal.

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

L-Trifluoromethionine (TFM), a potential prodrug, was reported to be toxic toward human pathogens that express L-methionine γ-lyase (MGL; EC: 4.4.1.11), a pyridoxal phosphate-containing enzyme that converts L-methionine to α-ketobutyrate, ammonia and methyl mercaptan. It has been hypothesized that the extremely reactive thiocarbonyl difluoride is produced when the enzyme acts upon TFM, resulting in cellular toxicity. The potential application of the fluorinated thiomethyl group in other areas of biochemistry and medicinal chemistry requires additional studies. Therefore a detailed investigation of the theoretical and experimental chemistry and biochemistry of these fluorinated groups (CF3S- and CF2HS-) has been undertaken to trap and identify chemical intermediates produced by enzyme processing of molecules containing these fluorinated moieties. MGL from Trichomonas vaginalis (TvMGL) and a chemical model system of the reaction were utilized in order to investigate the cofactor-dependent activation of TFM and previously uninvestigated L-difluoromethionine (DFM). The differences in toxicity between TFM and DFM were evaluated against Escherichia coli expressing TvMGL1, as well as the intact human pathogen, T. vaginalis. The relationship between the chemical structure of the reactive intermediates produced from the enzymatic processing of these analogs and their cellular toxicity are discussed.